Mori, Y.
Kasai, H.
Ose, A.
Serada, M.
Ishiguro, M.
Shiraki, M.
Tanigawara, Y. http://orcid.org/0000-0002-6309-955X
Funding for this research was provided by:
Asahi Kasei Pharma Corporation
Article History
Received: 12 October 2017
Accepted: 2 January 2018
First Online: 8 February 2018
Compliance with ethical standards
: This study was conducted in compliance with the World Medical Association Declaration of Helsinki–Ethical Principles for Medical Research Involving Human Subjects and Good Clinical Practice. The protocol was approved by the institutional review board at each study site. Written, informed consent was obtained from all subjects before enrollment in the study.
: Yoko Mori, Atsushi Ose, Masashi Serada, and Masashi Ishiguro are employees of Asahi Kasei Pharma. Hidefumi Kasai and Masataka Shiraki received consulting fees from Asahi Kasei Pharma. Yusuke Tanigawara received research funds from Asahi Kasei Pharma.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.